Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 9.8a
Adjusted Graft Survival, Deceased Donor Liver Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
11,192
91.7%
0.3%
11,192
85.3%
0.3%
33,183
68.4%
0.3%
55,317
54.4%
0.3%
Transplant Center State
Alabama
198
94.4%
1.6%
198
89.4%
2.2%
523
74.1%
2.4%
953
60.5%
2.2%
Arkansas
52
96.2%
2.6%
52
92.4%
3.6%
92
84.1%
5.0%
92
84.1%
5.0%
Arizona
217
95.9%
1.3%
217
90.4%
2.0%
505
75.8%
2.4%
724
59.8%
3.3%
California
1,256
92.4%
0.8%
1,256
86.1%
1.0%
3,806
71.3%
0.9%
6,657
58.4%
0.8%
Colorado
166
91.6%
2.1%
166
85.6%
2.7%
482
77.2%
2.2%
821
65.8%
2.4%
Connecticut
76
92.0%
3.1%
76
84.1%
4.2%
185
69.4%
4.0%
344
55.9%
3.5%
District of Columbia
114
90.2%
2.8%
114
87.5%
3.1%
321
66.6%
3.2%
473
56.9%
3.0%
Delaware
9
87.0%
11.5%
9
74.2%
14.9%
36
66.1%
10.2%
53
68.7%
8.0%
Florida
1,103
92.7%
0.8%
1,103
86.1%
1.0%
3,197
69.0%
1.0%
5,439
54.0%
1.0%
Georgia
284
92.9%
1.5%
284
85.0%
2.1%
747
60.2%
2.3%
1,148
47.5%
2.3%
Hawaii
25
92.2%
5.2%
25
88.2%
6.3%
74
72.0%
6.1%
123
69.8%
5.0%
Iowa
47
95.8%
2.9%
47
93.8%
3.5%
148
81.8%
3.4%
351
57.9%
3.7%
Illinois
403
87.6%
1.6%
403
78.0%
2.1%
1,394
62.2%
1.5%
2,320
48.6%
1.5%
Indiana
231
93.1%
1.7%
231
85.8%
2.3%
821
69.7%
1.9%
1,176
52.8%
2.8%
Kansas
132
91.0%
2.5%
132
88.8%
2.7%
289
71.9%
3.7%
470
51.9%
3.8%
Kentucky
163
88.4%
2.5%
163
82.2%
3.0%
490
68.3%
2.4%
756
54.9%
2.8%
Louisiana
269
92.6%
1.6%
269
88.2%
2.0%
832
68.9%
1.8%
1,362
51.6%
2.1%
Massachusetts
215
87.4%
2.3%
215
80.0%
2.7%
724
66.4%
2.0%
1,306
54.1%
1.9%
Maryland
196
85.6%
2.5%
196
72.8%
3.2%
504
56.4%
2.6%
807
46.3%
2.5%
Michigan
364
93.7%
1.3%
364
86.7%
1.8%
1,041
66.7%
1.7%
1,614
54.5%
1.9%
Minnesota
246
90.8%
1.8%
246
86.0%
2.2%
745
72.2%
1.9%
1,370
60.0%
1.9%
Missouri
282
90.7%
1.7%
282
85.4%
2.1%
790
68.8%
2.1%
1,237
57.7%
2.0%
North Carolina
250
91.2%
1.8%
250
83.1%
2.4%
709
64.4%
2.1%
1,301
53.7%
1.9%
Nebraska
148
93.8%
2.0%
148
84.9%
3.0%
480
69.1%
2.4%
906
57.2%
2.2%
New Jersey
139
95.7%
1.7%
139
89.3%
2.6%
468
67.8%
2.4%
833
57.7%
2.2%
New Mexico
0
-
-
0
-
-
0
-
-
29
58.5%
8.9%
New York
829
87.4%
1.1%
829
79.4%
1.4%
2,758
59.8%
1.1%
4,383
47.9%
1.1%
Ohio
458
93.5%
1.1%
458
88.3%
1.5%
1,293
67.9%
1.6%
2,061
54.7%
1.6%
Oklahoma
113
93.9%
2.2%
113
91.3%
2.6%
347
74.8%
2.7%
591
65.5%
2.8%
Oregon
104
100.0%
0.0%
104
92.5%
2.5%
293
81.2%
2.6%
527
61.3%
3.1%
Pennsylvania
816
91.4%
1.0%
816
83.7%
1.3%
2,626
65.6%
1.1%
4,531
49.9%
1.1%
South Carolina
118
91.5%
2.6%
118
85.6%
3.2%
303
74.9%
3.0%
600
49.6%
3.0%
Tennessee
387
92.5%
1.3%
387
86.6%
1.7%
880
66.9%
2.1%
1,359
54.1%
2.0%
Texas
967
93.3%
0.8%
967
88.5%
1.0%
2,859
72.2%
1.0%
4,608
57.5%
1.1%
Utah
117
93.1%
2.3%
117
86.2%
3.2%
330
75.7%
2.7%
540
61.2%
3.5%
Virginia
232
89.4%
2.0%
232
84.7%
2.3%
607
72.2%
2.1%
1,011
45.6%
2.6%
Washington
204
93.1%
1.8%
204
89.2%
2.2%
704
74.1%
1.9%
1,087
56.4%
2.6%
Wisconsin
262
87.4%
2.0%
262
81.6%
2.4%
780
69.4%
1.9%
1,354
53.9%
2.0%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Graft survival follows individual transplants until graft failure.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on liver transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.